Pfizer cuts 330 jobs in Italy as JPMorgan lifts target for Pfizer stock
Published on 10/13/2026 at 12:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- Pfizer plans 330 job cuts at its Catania plant in Italy, adding to its restructuring program.
- JPMorgan raised its Pfizer price target from USD 28.00 to USD 30.00 between October 6 and October 9, 2026.
- Pfizer stock was trading at EUR 25.59 at Lang & Schwarz on October 13, 2026, plus 0.63 percent versus the Xetra close of EUR 25.43 on October 12, 2026.
- Pfizer reported USD 15.03 billion in second-quarter 2026 revenue and USD 0.77 in adjusted diluted earnings per share.
Pfizer Inc. (ISIN US7170811035) was trading at EUR 25.59 at Lang & Schwarz on October 13, 2026 at 11:55 a.m. CEST, up 0.63 percent versus the Xetra close of EUR 25.43 on October 12, 2026. The company planned to cut 330 jobs at its Catania plant in Italy, while JPMorgan raised its Pfizer price target from USD 28.00 to USD 30.00 between October 6 and October 9, 2026, according to Yahoo Finance.
Three dated operating signals
On October 2, 2026, Yahoo Finance published Pfizer's second-quarter 2026 earnings-call transcript, which reported USD 15.03 billion in revenue and adjusted diluted earnings per share of USD 0.77. On October 8, 2026, Cantor Fitzgerald lifted its price target from USD 27.00 to USD 28.00, as reported by MarketBeat. On October 12, 2026, Barchart reported the planned 330 job cuts and the closure of the plant's penicillin department.
What does the outlook change?
Pfizer's second-quarter revenue rose 2.6 percent year over year to USD 15.03 billion, while adjusted diluted earnings per share declined from USD 0.78 to USD 0.77, according to Yahoo Finance. Pfizer raised its full-year 2026 revenue outlook by USD 500 million at the midpoint to USD 60.50 billion-USD 62.50 billion from USD 59.50 billion-USD 60.50 billion, while retaining adjusted diluted earnings-per-share guidance of USD 2.80-USD 3.00.
The operating picture is mixed. Launched and acquired products grew 18 percent operationally in the second quarter of 2026, but the quarter also included USD 4.30 billion in non-cash intangible-asset impairments, according to Yahoo Finance. That combination makes cost savings and the product transition more important than the headline revenue increase.
Upcoming dates and analyst view
Pfizer's next quarterly results are scheduled for November 3, 2026, while the dividend record date is November 6, 2026, according to Yahoo Finance and MarketBeat. JPMorgan's USD 30.00 target and Scotiabank's USD 33.00 target show that analyst expectations have moved higher, but both figures remain targets in US dollars rather than euro price references.
Pfizer stock stays near its yearly high
Pfizer stock was trading at EUR 25.59 at Lang & Schwarz on October 13, 2026 at 11:55 a.m. CEST, plus 0.63 percent versus the Xetra close of EUR 25.43 on October 12, 2026. The quote stood EUR 0.01 below the EUR 25.60 52-week high in the same euro market snapshot, while Pfizer's market capitalization was EUR 145.8 billion.
The further course of trading is shown by the continuously updated real-time quote of Pfizer stock.
Pfizer stock facts
- Company: Pfizer Inc.
- ISIN: US7170811035
- Ticker: PFE
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 13, 2026, 11:55 a.m. CEST): EUR 25.59
- Change versus Xetra close: plus 0.63 percent
- Xetra close (October 12, 2026): EUR 25.43
- Market capitalization: EUR 145.8 billion (as of October 13, 2026)
- 52-week range: EUR 20.52-EUR 25.60 (as of October 13, 2026)
- Sector / Industry: Healthcare / Drug Manufacturers - General
- Next earnings date: November 3, 2026
Market context: Market report S&P 500.
